Using Telerehabilitation Tools to Deliver Quality Therapy to Patients Under Infective Isolation Precautions

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-11-15

Study Completion Date

2019-12-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Single blinded Randomised Controlled trial comparing standard therapy to the intervention of up to 1 hour of physiotherapist-prescribed resistive training exercises administered via a telerehabilitation device per day in addition to standard therapy for a total of 10 sessions over a 2 week period. Total recruitment: 60 patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluating the Technology and Assessing the Biological Effects of Commercially Available PhotoBioModulation Devices

NCT06403644

Physiological Wellness

RECRUITING NA

Randomized Controlled Single-blind Non-inferiority Trial Comparing an Offer of Initial Virtual Visit and Usual Care

NCT07093164

Musculoskeletal Diseases

WITHDRAWN NA

Near-Infrared Spectroscopy-Guided Exercise Training in Peripheral Arterial Disease

NCT03478085

Peripheral Arterial Disease

COMPLETED EARLY_PHASE1

Effects of Green Light Therapy on Body Contouring and Cellulite

NCT03647748

Fat Reduction

COMPLETED NA

Graphene Photothermal Adjuvant Therapy for Mild Corona Virus Disease 2019: A Prospective Randomized Controlled Trial

NCT05651815

COVID-19

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a single blinded randomised control trial. From August 2018 to March 2019, a total of 60 subjects, who match the inclusion exclusion criteria, will be recruited from patients transferred to the SGH Isolation wards.

They will be randomly assigned to control or treatment arm based on a block randomisation strategy predetermined and held by an independent party.

The treatment arm will be given up to 1 hour of physiotherapist-prescribed resistive training exercises administered via a telerehabilitation device per day in addition to standard therapy for a total of 10 sessions over a 2 week period. They will be evaluated for motor strength, activity of daily living performance, mood and perceived level of health.

The control arm will be subject to the same assessments as the treatment arm at the start and end of the two week period. They will receive standard care in the ward including physiotherapy as prescribed by the managing team.

The assessors will be blinded to the arm of the study the subjects will be assigned to and will be independent of the terating physiotherapist.

1.1. Hypothesis We propose that for patients with deconditioning after a prolonged period of hospitalization and needing inpatient isolation precautions, that a 2-week course of daily, up to 1-hour long, physiotherapist-developed resistive training exercises will result in a 20% improvement in the motor power and a corresponding improvement in motor functioning and the perceived quality of life compared to a control group receiving standard therapy.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Deconditioning, Isolation Precautions

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Two arm single blinded RCT

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Block Randomisation, Initial and final outcome assessors blinded to treatment arm

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Conventional therapy

The control arm will be subject to the same assessments as the treatment arm at the start and end of the two week period. They will receive standard care in the ward including physiotherapy as prescribed by the managing team

Group Type NO_INTERVENTION

No interventions assigned to this group

Intervention arm

The treatment arm will be given up to 1 hour of physiotherapist-prescribed resistive training exercises administered via a telerehabilitation device per day in addition to standard therapy for a total of 10 sessions over a 2 week period. They will be evaluated for motor strength, activity of daily living performance, mood and perceived level of health.

Group Type EXPERIMENTAL

Telerehabilitation

Intervention Type DEVICE

The treatment arm will be given up to 1 hour of physiotherapist-prescribed resistive training exercises administered via a telerehabilitation device per day in addition to standard therapy for a total of 10 sessions over a 2 week period.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Telerehabilitation

The treatment arm will be given up to 1 hour of physiotherapist-prescribed resistive training exercises administered via a telerehabilitation device per day in addition to standard therapy for a total of 10 sessions over a 2 week period.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* • Able to give consent

* Admitted to hospital for at least 5 days
* MMT power grading 2-4/5
* Isolated for prevention of transmission of MDROs

Exclusion Criteria

* • Unable or unwilling to consent for the trial

* Assessed by managing team to be fit for discharge within the next 2 weeks
* Pregnant women
* Underlying medical disorders that result in pre-existing lower limb weakness

Minimum Eligible Age

21 Years

Maximum Eligible Age

99 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No